Page 145 - Read Online

D’Arcangelo et al. Hepatoma Res 2021;7:4 I http://dx.doi.org/10.20517/2394-5079.2020.109 Page 11 of 12

REFERENCES
1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2),
and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16-31.
2. Bhanji RA, Narayanan P, Moynagh MR, et al. Differing impact of sarcopenia and frailty in nonalcoholic steatohepatitis and alcoholic
liver disease. Liver Transpl 2019;25:14-24.
3. Carey EJ, Lai JC, Wang CW, et al; Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicenter study to
define sarcopenia in patients with end-stage liver disease. Liver Transpl 2017;23:625-33.
4. Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the
functional assessment in liver transplantation (FrAILT) study. Hepatology 2016;63:574-80.
5. Stirnimann G, Ebadi M, Tandon P, Montano-Loza AJ. Should sarcopenia increase priority for transplant or is it a contraindication? Curr
Gastroenterol Rep 2018;20:50.
6. Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent
prognostic value. Liver Transpl 2012;18:1209-16.
7. van Vugt JLA, Alferink LJM, Buettner S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list
mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol 2018;68:707-14.
8. van Vugt JLA, Buettner S, Alferink LJM, et al. Low skeletal muscle mass is associated with increased hospital costs in patients with
cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018;31:165-74.
9. Yadav A, Chang YH, Carpenter S, et al. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in
liver transplant candidates. Clin Transplant 2015;29:134-41.
10. Ebadi M, Montano-Loza AJ. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. Dig Liver Dis 2019;51:1493-9.
11. Pinto Dos Santos D, Kloeckner R, Koch S, et al. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J
Gastroenterol Hepatol 2020;32:626-34.
12. van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact
of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J
Transplant 2016;16:2277-92.
13. Aby ES, Lee E, Saggi SS, et al. Pretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality. J
Clin Gastroenterol 2019;53:680-5.
14. DiMartini A, Cruz RJ Jr, Dew MA, et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013;19:1172-80.
15. Engelmann C, Schob S, Nonnenmacher I, et al. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts
complications and death. Aliment Pharmacol Ther 2018;48:1271-81.
16. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010;211:271-8.
17. Golse N, Bucur PO, Ciacio O, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver
Transpl 2017;23:143-54.
18. Montano-Loza AJ, Meza-Junco J, Baracos VE, et al. Severe muscle depletion predicts postoperative length of stay but is not associated
with survival after liver transplantation. Liver Transpl 2014;20:640-8.
19. Ooi PH, Hager A, Mazurak VC, et al. Sarcopenia in chronic liver disease: impact on outcomes. Liver Transpl 2019;25:1422-38.
20. Underwood PW, Cron DC, Terjimanian MN, Wang SC, Englesbe MJ, Waits SA. Sarcopenia and failure to rescue following liver
transplantation. Clin Transplant 2015;29:1076-80.
21. Burra P, Belli LS, Ginanni Corradini S, et al. Common issues in the management of patients in the waiting list and after liver
transplantation. Dig Liver Dis 2017;49:241-53.
22. Burra P, Giannini EG, Caraceni P, et al. Specific issues concerning the management of patients on the waiting list and after liver
transplantation. Liver Int 2018;38:1338-62.
23. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and
management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65:310-35.
24. Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000Res 2019;8:966.
25. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol
2018;69:182-236.
26. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with
cirrhosis. N Engl J Med 1996;334:693-9.
27. Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of
the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle 2017;8:113-21.
28. Valero V 3rd, Amini N, Spolverato G, et al. Sarcopenia adversely impacts postoperative complications following resection or
transplantation in patients with primary liver tumors. J Gastrointest Surg 2015;19:272-81.
29. Becchetti C, Bosch J. Muscle abnormalities in cirrhosis: calling for more strength in evaluation and prevention. Dig Liver Dis
2019;51:1500-1.
30. Ebadi M, Wang CW, Lai JC, et al; From the fitness, life enhancement, and exercise in liver transplantation (FLEXIT) Consortium. Poor
performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J Cachexia Sarcopenia
Muscle 2018;9:1053-62.
31. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: liver transplantation. J Hepatol 2016;64:433-85.
32. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated